SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-245200
Filing Date
2010-11-03
Accepted
2010-11-03 06:07:54
Documents
4
Period of Report
2010-11-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 19477
2 AGREEMENT AND PLAN OF MERGER dex21.htm EX-2.1 574378
3 PRESS RELEASE dex991.htm EX-99.1 19711
4 GRAPHIC g114140ex99_1.jpg GRAPHIC 22263
  Complete submission text file 0001193125-10-245200.txt   646597
Mailing Address
Business Address 16825 NORTHCHASE DR STE 1300 HOUSTON TX 77060 2818732674
US ONCOLOGY INC (Filer) CIK: 0000943061 (see all company filings)

IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26190 | Film No.: 101159903
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

Mailing Address 16825 NORTHCHASE DRIVE, SUITE 1300 HOUSTON TX 77060
Business Address 16825 NORTHCHASE DRIVE, SUITE 1300 HOUSTON TX 77060 (832) 601-8766
US Oncology Holdings, Inc. (Filer) CIK: 0001333191 (see all company filings)

IRS No.: 200873619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-126922 | Film No.: 101159902
SIC: 8060 Services-Hospitals